Same Drug Class

Osimertinib vs Tofacitinib

Osimertinib vs Tofacitinib: Overview

This comparison examines the pharmacological differences between Osimertinib and Tofacitinib.

Mechanism of Action

Osimertinib: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.

Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.

Pharmacokinetics

Half-life: Osimertinib β€” 48 hours; Tofacitinib β€” 3.2 hours.

Chemical Properties

Molecular Formula: Osimertinib β€” C28H33N7O2; Tofacitinib β€” C16H20N6O.

Molecular Weight: Osimertinib β€” 499.6050 g/mol; Tofacitinib β€” 312.3700 g/mol.

Type: Osimertinib β€” Small molecule; Tofacitinib β€” Small molecule.